115 related articles for article (PubMed ID: 38736017)
1. Retraction Note: Ensemble learning-based gene signature and risk model for predicting prognosis of triple-negative breast cancer.
Li T; Chen S; Zhang Y; Zhao Q; Ma K; Jiang X; Xiang R; Zhai F; Ling G
Funct Integr Genomics; 2024 May; 24(3):95. PubMed ID: 38736017
[No Abstract] [Full Text] [Related]
2. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.
Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X
Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184
[TBL] [Abstract][Full Text] [Related]
3. Ensemble learning-based gene signature and risk model for predicting prognosis of triple-negative breast cancer.
Li T; Chen S; Zhang Y; Zhao Q; Ma K; Jiang X; Xiang R; Zhai F; Ling G
Funct Integr Genomics; 2023 Mar; 23(2):81. PubMed ID: 36917262
[TBL] [Abstract][Full Text] [Related]
4. Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancer.
Lv X; He M; Zhao Y; Zhang L; Zhu W; Jiang L; Yan Y; Fan Y; Zhao H; Zhou S; Ma H; Sun Y; Li X; Xu H; Wei M
Cancer Cell Int; 2019; 19():172. PubMed ID: 31297036
[TBL] [Abstract][Full Text] [Related]
5. Notch-based gene signature for predicting the response to neoadjuvant chemotherapy in triple-negative breast cancer.
Omar M; Nuzzo PV; Ravera F; Bleve S; Fanelli GN; Zanettini C; Valencia I; Marchionni L
J Transl Med; 2023 Nov; 21(1):811. PubMed ID: 37964363
[TBL] [Abstract][Full Text] [Related]
6. Identification and Validation of a Novel Glycolysis-Related Gene Signature for Predicting the Prognosis and Therapeutic Response in Triple-Negative Breast Cancer.
Zheng J; Zhang YF; Han GH; Fan MY; Du MH; Zhang GC; Zhang B; Qiao J; Zhang SX; Cao JM
Adv Ther; 2023 Jan; 40(1):310-330. PubMed ID: 36316558
[TBL] [Abstract][Full Text] [Related]
7. Identification of a prognostic LncRNA signature for ER-positive, ER-negative and triple-negative breast cancers.
Liu D
Breast Cancer Res Treat; 2020 Aug; 183(1):95-105. PubMed ID: 32601968
[TBL] [Abstract][Full Text] [Related]
8. Combined mRNAs and clinical factors model on predicting prognosis in patients with triple-negative breast cancer.
Hu Y; Zou D
PLoS One; 2021; 16(12):e0260811. PubMed ID: 34965257
[TBL] [Abstract][Full Text] [Related]
9. Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.
Kuo WH; Chang YY; Lai LC; Tsai MH; Hsiao CK; Chang KJ; Chuang EY
PLoS One; 2012; 7(9):e45831. PubMed ID: 23049873
[TBL] [Abstract][Full Text] [Related]
10. An exosome-based specific transcriptomic signature for profiling regulation patterns and modifying tumor immune microenvironment infiltration in triple-negative breast cancer.
Wang H; Wang R; Luo L; Hong J; Chen X; Shen K; Wang Y; Huang R; Wang Z
Front Immunol; 2023; 14():1295558. PubMed ID: 38124743
[TBL] [Abstract][Full Text] [Related]
11. A novel immune checkpoint-related gene signature for predicting overall survival and immune status in triple-negative breast cancer.
Liu J; Ling Y; Su N; Li Y; Tian S; Hou B; Luo S; Zhao L; Shi M
Transl Cancer Res; 2022 Jan; 11(1):181-192. PubMed ID: 35261895
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cell-related prognostic risk model predicts prognosis and treatment outcomes in triple-negative breast cancer.
Liu Z; Ding M; Qiu P; Pan K; Guo Q
Front Immunol; 2023; 14():1200282. PubMed ID: 37520534
[TBL] [Abstract][Full Text] [Related]
13. A serum LncRNA signature for predicting prognosis of triple-negative breast cancer.
Zhu T; Wang J; Li J; Zhang Q; Shang Y; Zhou J; Min L; Lv B; Luo K
Clin Chim Acta; 2023 Sep; 549():117535. PubMed ID: 37690662
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a novel 15-CpG-based signature for predicting prognosis in triple-negative breast cancer.
Peng Y; Shui L; Xie J; Liu S
J Cell Mol Med; 2020 Aug; 24(16):9378-9387. PubMed ID: 32649035
[TBL] [Abstract][Full Text] [Related]
15. An iron metabolism and immune related gene signature for the prediction of clinical outcome and molecular characteristics of triple-negative breast cancer.
Li XF; Fu WF; Zhang J; Song CG
BMC Cancer; 2022 Jun; 22(1):619. PubMed ID: 35668369
[TBL] [Abstract][Full Text] [Related]
16. A novel tumor-associated neutrophil gene signature for predicting prognosis, tumor immune microenvironment, and therapeutic response in breast cancer.
Zhang J; Wang X; Zhang Z; Ma F; Wang F
Sci Rep; 2024 Mar; 14(1):5339. PubMed ID: 38438469
[TBL] [Abstract][Full Text] [Related]
17. A novel model associated with tumor microenvironment on predicting prognosis and immunotherapy in triple negative breast cancer.
Zhang J; Zhang M; Tian Q; Yang J
Clin Exp Med; 2023 Nov; 23(7):3867-3881. PubMed ID: 37219794
[TBL] [Abstract][Full Text] [Related]
18. Autophagy-related prognostic signature for survival prediction of triple negative breast cancer.
Yang Q; Sun K; Xia W; Li Y; Zhong M; Lei K
PeerJ; 2022; 10():e12878. PubMed ID: 35186475
[TBL] [Abstract][Full Text] [Related]
19. A Novel Platelet-Related Gene Signature for Predicting the Prognosis of Triple-Negative Breast Cancer.
Xie J; Zou Y; Ye F; Zhao W; Xie X; Ou X; Xie X; Wei W
Front Cell Dev Biol; 2021; 9():795600. PubMed ID: 35096824
[TBL] [Abstract][Full Text] [Related]
20. Identification of prognostic genes for recurrent risk prediction in triple negative breast cancer patients in Taiwan.
Chen LH; Kuo WH; Tsai MH; Chen PC; Hsiao CK; Chuang EY; Chang LY; Hsieh FJ; Lai LC; Chang KJ
PLoS One; 2011; 6(11):e28222. PubMed ID: 22140552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
